• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

治疗期间胃食管反流病症状的评估。第二部分。糜烂性胃食管反流病中新型问卷ReQuest的心理测量评估与验证。

Evaluation of GERD symptoms during therapy. Part II. Psychometric evaluation and validation of the new questionnaire ReQuest in erosive GERD.

作者信息

Mönnikes H, Bardhan K D, Stanghellini V, Berghöfer P, Bethke T D, Armstrong D

机构信息

Department of Medicine, Charité, Freie Universität, DE-13353 Berlin, Germany.

出版信息

Digestion. 2004;69(4):238-44. doi: 10.1159/000079708. Epub 2004 Jul 12.

DOI:10.1159/000079708
PMID:15256830
Abstract

BACKGROUND/AIMS: Evaluation of the response of gastroesophageal reflux disease (GERD) symptoms to treatment would be facilitated by a brief, valid, reliable and responsive, self-assessed GERD-sensitive scale. We therefore developed the Reflux Questionnaire (ReQuest). This publication describes the psychometric evaluation and validation of ReQuest.

METHODS

This second phase of development was based on data from a clinical trial of patients with erosive GERD who received pantoprazole 20 or 40 mg daily for 28 days and completed weekly the long, and daily the short version of ReQuest. The psychometric analyses of ReQuest included internal consistency, test-retest reliability and responsiveness. Construct validity was evaluated by comparison with the Gastrointestinal Symptom Rating Scale (GSRS) and the Psychological General Well-Being (PGWB) scale.

RESULTS

Validation of ReQuest indicated very high internal consistency (Cronbach's alpha = 0.90) and test-retest reliability (intraclass correlation coefficient 0.94 (long-long) and 0.86 (short-short)). This was also the case for the two subscales ReQuest-GI and ReQuest-WSO with Cronbach's alpha coefficients of 0.84 and 0.81. Responsiveness was high with a responsiveness index of >0.8 at day 28. Construct validity was good.

CONCLUSION

ReQuest is a highly reliable, valid and responsive self-assessment tool for evaluating treatment response in patients with erosive GERD, and can be applied daily.

摘要

背景/目的:一份简短、有效、可靠且具有反应性的自我评估胃食管反流病(GERD)敏感量表,将有助于评估GERD症状对治疗的反应。因此,我们开发了反流问卷(ReQuest)。本出版物描述了ReQuest的心理测量学评估和验证。

方法

这一开发的第二阶段基于一项针对糜烂性GERD患者的临床试验数据,这些患者每天接受20或40毫克泮托拉唑治疗28天,并每周完成一次长版本以及每天完成一次短版本的ReQuest。ReQuest的心理测量学分析包括内部一致性、重测信度和反应性。通过与胃肠道症状评定量表(GSRS)和心理总体幸福感(PGWB)量表进行比较来评估结构效度。

结果

ReQuest的验证表明其具有非常高的内部一致性(克朗巴哈系数α = 0.90)和重测信度(组内相关系数,长版本 - 长版本为0.94,短版本 - 短版本为0.86)。ReQuest - GI和ReQuest - WSO这两个子量表的克朗巴哈系数分别为0.84和0.81,情况也是如此。在第28天时反应性较高,反应性指数>0.8。结构效度良好。

结论

ReQuest是一种高度可靠、有效且具有反应性的自我评估工具,可以应用于糜烂性GERD患者的治疗反应评估,并且可以每天使用。

相似文献

1
Evaluation of GERD symptoms during therapy. Part II. Psychometric evaluation and validation of the new questionnaire ReQuest in erosive GERD.治疗期间胃食管反流病症状的评估。第二部分。糜烂性胃食管反流病中新型问卷ReQuest的心理测量评估与验证。
Digestion. 2004;69(4):238-44. doi: 10.1159/000079708. Epub 2004 Jul 12.
2
Evaluation of GERD symptoms during therapy. Part II. Psychometric evaluation and validation of the new questionnaire ReQuest in erosive GERD.治疗期间胃食管反流病(GERD)症状的评估。第二部分。糜烂性GERD中新型问卷ReQuest的心理测量评估与验证
Digestion. 2007;75 Suppl 1:41-7. doi: 10.1159/000101081. Epub 2007 May 4.
3
ReQuest-- the challenge of quantifying both esophageal and extra-esophageal manifestations of GERD.ReQuest——量化胃食管反流病食管及食管外表现的挑战。
Best Pract Res Clin Gastroenterol. 2004;18 Suppl:27-30. doi: 10.1016/j.bpg.2004.06.009.
4
International validation of ReQuest in patients with endoscopy-negative gastro-oesophageal reflux disease.ReQuest在胃镜检查阴性的胃食管反流病患者中的国际验证
Aliment Pharmacol Ther. 2004 Oct 15;20(8):891-8. doi: 10.1111/j.1365-2036.2004.02194.x.
5
Evaluation of GERD symptoms during therapy. Part I. Development of the new GERD questionnaire ReQuest.治疗期间胃食管反流病(GERD)症状的评估。第一部分。新型GERD问卷ReQuest的研制。
Digestion. 2004;69(4):229-37. doi: 10.1159/000079707. Epub 2004 Jul 9.
6
International validation of ReQuest in patients with endoscopy-negative gastro-oesophageal reflux disease.ReQuest在胃镜检查阴性的胃食管反流病患者中的国际验证
Digestion. 2007;75 Suppl 1:48-54. doi: 10.1159/000101082. Epub 2007 May 4.
7
Look--but also listen! ReQuest: an essay on a new validated scale to assess the outcome of GERD treatment.看——但也要听!《请求》:一篇关于一种新的经过验证的评估胃食管反流病(GERD)治疗结果量表的文章。
Digestion. 2007;75 Suppl 1:87-100. doi: 10.1159/000101020. Epub 2007 May 4.
8
Development and validation of a disease-specific quality of life questionnaire for gastro-oesophageal reflux disease: the GERD-QOL questionnaire.开发和验证一种用于胃食管反流病的疾病特异性生活质量问卷:胃食管反流病生活质量问卷(GERD-QOL 问卷)。
Aliment Pharmacol Ther. 2010 Feb 1;31(3):452-60. doi: 10.1111/j.1365-2036.2009.04187.x. Epub 2009 Oct 31.
9
Evaluation of GERD symptoms during therapy. Part I. Development of the new GERD questionnaire ReQuest.治疗期间胃食管反流病(GERD)症状的评估。第一部分。新型GERD问卷ReQuest的开发。
Digestion. 2007;75 Suppl 1:32-40. doi: 10.1159/000101080. Epub 2007 May 4.
10
Determination of ReQuest-based symptom thresholds to define symptom relief in GERD clinical studies.在胃食管反流病临床研究中确定基于需求的症状阈值以定义症状缓解情况。
Digestion. 2005;71(3):145-51. doi: 10.1159/000085564. Epub 2005 May 4.

引用本文的文献

1
Validation of Esophageal Global Symptom Severity as a Patient-Reported Outcome for Evaluation of Reflux Symptoms.食管整体症状严重程度作为患者报告结局用于评估反流症状的验证
Am J Gastroenterol. 2025 Apr 23;120(8):1760-1769. doi: 10.14309/ajg.0000000000003499.
2
Patient-Reported Outcome Measures in Benign Esophageal Disorders.良性食管疾病的患者报告结局指标
Am J Gastroenterol. 2025 Apr 7. doi: 10.14309/ajg.0000000000003467.
3
Factors influencing treatment outcome in patients with gastroesophageal reflux disease: outcome of a prospective pragmatic trial in Asian patients.
影响胃食管反流病患者治疗结局的因素:一项针对亚洲患者的前瞻性实用试验的结果
BMC Gastroenterol. 2014 Sep 9;14:156. doi: 10.1186/1471-230X-14-156.
4
Relief of Night-time Symptoms Associated With Gastroesophageal Reflux Disease Following 4 Weeks of Treatment With Pantoprazole Magnesium: The Mexican Gastroesophageal Reflux Disease Working Group.泮托拉唑镁治疗 4 周后缓解胃食管反流病夜间症状:墨西哥胃食管反流病工作组。
J Neurogastroenterol Motil. 2014 Jan;20(1):64-73. doi: 10.5056/jnm.2014.20.1.64. Epub 2013 Dec 30.
5
Development of an online library of patient-reported outcome measures in gastroenterology: the GI-PRO database.开发一个在线胃肠道患者报告结局测量库:GI-PRO 数据库。
Am J Gastroenterol. 2014 Feb;109(2):234-48. doi: 10.1038/ajg.2013.401. Epub 2013 Dec 17.
6
Physicians and patients measure different dimension on assessment for gastroesophageal reflux disease-related symptoms [corrected].医生和患者在评估胃食管反流病相关症状时测量的维度不同[已纠正]。
J Neurogastroenterol Motil. 2011 Oct;17(4):381-6. doi: 10.5056/jnm.2011.17.4.381. Epub 2011 Oct 31.
7
Influence of irritable bowel syndrome on treatment outcome in gastroesophageal reflux disease.肠易激综合征对胃食管反流病治疗效果的影响。
World J Gastroenterol. 2011 Jul 21;17(27):3235-41. doi: 10.3748/wjg.v17.i27.3235.
8
Questionnaire based gastroesophageal reflux disease (GERD) assessment scales.基于问卷的胃食管反流病(GERD)评估量表。
Indian J Gastroenterol. 2011 May;30(3):108-17. doi: 10.1007/s12664-011-0105-9. Epub 2011 Jul 23.
9
Prediction of response to PPI therapy and factors influencing treatment outcome in patients with GORD: a prospective pragmatic trial using pantoprazole.胃食管反流病患者对 PPI 治疗的反应预测和影响治疗结果的因素:一项使用泮托拉唑的前瞻性实用试验。
BMC Gastroenterol. 2011 May 11;11:52. doi: 10.1186/1471-230X-11-52.
10
Impact of PPIs on patient focused symptomatology in GERD.质子泵抑制剂对 GERD 患者为中心的症状学的影响。
Ther Clin Risk Manag. 2008 Dec;4(6):1185-200. doi: 10.2147/tcrm.s3132.